Lentiviral vectors: basic to translational
More than two decades have passed since genetically modified HIV was used for gene
delivery. Through continuous improvements these early marker gene-carrying HIVs have …
delivery. Through continuous improvements these early marker gene-carrying HIVs have …
Gene therapy: trials and tribulations
N Somia, IM Verma - Nature Reviews Genetics, 2000 - nature.com
The art and science of gene therapy has received much attention of late. The tragic death of
18-year-old Jesse Gelsinger, a volunteer in a Phase I clinical trial, has overshadowed the …
18-year-old Jesse Gelsinger, a volunteer in a Phase I clinical trial, has overshadowed the …
Epileptic seizures may begin hours in advance of clinical onset: a report of five patients
B Litt, R Esteller, J Echauz, M D'Alessandro, R Shor… - Neuron, 2001 - cell.com
Mechanisms underlying seizure generation are traditionally thought to act over seconds to
minutes before clinical seizure onset. We analyzed continuous 3-to 14-day intracranial EEG …
minutes before clinical seizure onset. We analyzed continuous 3-to 14-day intracranial EEG …
Gene therapy: twenty-first century medicine
IM Verma, MD Weitzman - Annu. Rev. Biochem., 2005 - annualreviews.org
▪ Abstract Broadly defined, the concept of gene therapy involves the transfer of genetic
material into a cell, tissue, or whole organ, with the goal of curing a disease or at least …
material into a cell, tissue, or whole organ, with the goal of curing a disease or at least …
Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations
RG Thorne, WH Frey - Clinical pharmacokinetics, 2001 - Springer
Neurotrophic factors are proteins with considerable potential in the treatment of central
nervous system (CNS) diseases and traumatic injuries. However, a significant challenge to …
nervous system (CNS) diseases and traumatic injuries. However, a significant challenge to …
Gene delivery by lentivirus vectors
AS Cockrell, T Kafri - Molecular biotechnology, 2007 - Springer
The capacity to efficiently transduce nondividing cells, shuttle large genetic payloads, and
maintain stable long-term transgene expression are attributes that have brought lentiviral …
maintain stable long-term transgene expression are attributes that have brought lentiviral …
Drug targeting to the brain
AG De Boer, PJ Gaillard - Annu. Rev. Pharmacol. Toxicol., 2007 - annualreviews.org
The central nervous system (CNS) is a sanctuary site and is protected by various barriers.
These regulate brain homeostasis and the transport of endogenous and exogenous …
These regulate brain homeostasis and the transport of endogenous and exogenous …
Gene therapy: promises and problems
Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or
at least to improve the clinical status of a patient. One of the basic concepts of gene therapy …
at least to improve the clinical status of a patient. One of the basic concepts of gene therapy …
A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression
KJ Shin, EA Wall, JR Zavzavadjian… - Proceedings of the …, 2006 - National Acad Sciences
RNAi is proving to be a powerful experimental tool for the functional annotation of
mammalian genomes. The full potential of this technology will be realized through …
mammalian genomes. The full potential of this technology will be realized through …
A versatile tool for conditional gene expression and knockdown
J Szulc, M Wiznerowicz, MO Sauvain, D Trono… - Nature …, 2006 - nature.com
Drug-inducible systems allowing the control of gene expression in mammalian cells are
invaluable tools for genetic research, and could also fulfill essential roles in gene-and cell …
invaluable tools for genetic research, and could also fulfill essential roles in gene-and cell …